. 2018 Nov 16;13:2367–2374. doi: 10.2147/CIA.S186199

Table 3.

Correlation analyses between sclerostin, FGF-23, and other parameters before and after treatment in the calcitriol group

	PTH	25(OH)₂D	CTX	ALP	Cr	UA	Serum Ca	Serum P	Urinary Ca	Grip strength (left)	Grip strength (right)	SOST	FGF-23
Pretreatment
SOST	0.138^0.20	0.102^0.34	−0.080^0.46	−0.134^0.21	0.047^0.67	0.020^0.85	0.005^0.96	−0.003^0.98	−0.143^0.18	0.093^0.55	−0.071^0.65	1	0.090^0.41
FGF-23	0.177^0.10	0.091^0.40	−0.182^0.09	−0.118^0.28	0.083^0.44	0.232^0.03	−0.048^0.66	0.012^0.91	0.013^0.91	0.057^0.71	0.048^0.76	0.090^0.41	1
Posttreatment
SOST	0.277^0.01	−0.057^0.60	0.069^0.53	−0.131^0.22	−0.006^0.96	−0.104^0.33	−0.096^0.37	−0.067^0.54	−0.2210^0.04	−0.3380^0.03	−0.291^0.06	1	0.045^0.68
FGF-23	0.015^0.89	−0.128^0.24	−0.3260^0.02	0.082^0.45	0.018^0.87	0.109^0.31	0.027^0.80	0.165^0.12	−0.3560^0.01	−0.036^0.82	−0.111^0.47	0.045^0.68	1

Note: Bold figures indicate statistically significant.

Abbreviations: 25(OH)₂D, serum 1,25-dihydroxyvitamin D; Ca, serum calcium; Cr, creatinine; CTX, cross-linked C-terminal telopeptide of type I collagen; FGF-23, fibroblast growth factor-23; Grip (left), grip strength of left hand; Grip (right), grip strength of right hand; PTH, parathyroid hormone; SOST, sclerostin; UA, uric acid; Urinary Ca, 24-hour urinary calcium.